Trademark: OPDUALAG NIVOLUMAB/RELATLIMAB)
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
OPDUALAG NIVOLUMAB/RELATLIMAB)
Click here to search for trademarks similar to OPDUALAG NIVOLUMAB/RELATLIMAB)
Proof of use for OPDUALAG NIVOLUMAB/RELATLIMAB)
We do not have any records of a proof of use for OPDUALAG NIVOLUMAB/RELATLIMAB) at this moment.
Click here to add a proof of use for OPDUALAG NIVOLUMAB/RELATLIMAB)
Possible trademark infringements of OPDUALAG NIVOLUMAB/RELATLIMAB)
Basic Information about OPDUALAG NIVOLUMAB/RELATLIMAB)
- Serial Number
- 88805781
- Filing Date
- 21 Feb 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of OPDUALAG NIVOLUMAB/RELATLIMAB) on the blockchain with WikiTrademarks.io.
- First use of OPDUALAG NIVOLUMAB/RELATLIMAB) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of OPDUALAG NIVOLUMAB/RELATLIMAB) anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns OPDUALAG NIVOLUMAB/RELATLIMAB)?
1. Bristol-Myers Squibb Company Princeton NJ
2. Bristol-Myers Squibb Company New York NY
Correspondent
- Marilyn F. Kelly
- BRISTOL-MYERS SQUIBB COMPANY
- P.O. BOX 4000
- TRADEMARK DEPT., MAILSTOP D.4243
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io